There was no difference in second primary cancer risk among older adult male patients treated with intensity-modulated radiotherapy (IMRT) vs 3-dimensional conformal radiation therapy for prostate ...
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately ...
Vancouver, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The global Intensity Modulated Radiotherapy (IMRT) market size was USD 2.21 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% ...
In a randomized trial of men with intermediate-risk prostate cancer, stereotactic body radiotherapy (SBRT) improved bowel-related quality of life vs moderately hypofractionated intensity-modulated ...
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy - proton beam therapy or intensity modulated radiation therapy (IMRT) - ...
Chicago, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The intensity-modulated radiotherapy (IMRT) industry is poised for a transformative evolution in the near future, driven by advancements in radiation ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved ...
With smaller radiation beams, intensity-modulated radiation therapy “takes precision to the next level” for patients with prostate, an expert told CURE®. Intensity-modulated radiation therapy (IMRT) — ...
The phase 3 NRG-GU005 trial compared moderately hypofractionated IMRT in 20 to 28 sessions vs SBRT in 5 sessions for efficacy and health-related quality-of-life in men with favorable intermediate-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results